title: SEOM clinical guidelines for the systemic treatment of early breast cancer 2013.
abstract: The purpose of this article is to update our previous work on the treatment and follow-up in early breast cancer. In this new version we have classified a treatment by immunohistochemistry subtypes of breast cancer. Latest advances in the management of this disease have been compiled, either in the adjuvant and neoadjuvant setting or chemotherapy and hormonal treatment. This review is presented in an easy way for oncologist, fellows and for other specialties.
authors: Medical Oncology Department, Hospital Dr. Josep Trueta, Institut Català d'Oncologia (ICO), Girona, Spain.
authors: S
authors: S
authors: Del Barco
authors: E
authors: E
authors: Ciruelos
authors: I
authors: I
authors: Tusquets
authors: M
authors: M
authors: Ruiz
authors: A
authors: A
authors: Barnadas
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D017024:Chemotherapy, Adjuvant / Q000592:standards; D005260:Female; D018734:Genes, erbB-2; D006801:Humans; D008991:Monitoring, Physiologic / Q000592:standards; D020360:Neoadjuvant Therapy / Q000592:standards; D009367:Neoplasm Staging
chemical_list: D018931:Antineoplastic Agents, Hormonal
references: N Engl J Med. 2005 Jun 2;352(22):2302-13
references: 15930421
references: Lancet. 2012 Feb 4;379(9814):432-44
references: 22152853
references: J Clin Oncol. 2012 May 20;30(15):1796-804
references: 22508812
references: J Natl Cancer Inst. 2008 Oct 1;100(19):1380-8
references: 18812550
references: Ann Oncol. 2011 Aug;22(8):1736-47
references: 21709140
references: Lancet. 2013 Mar 9;381(9869):805-16
references: 23219286
references: Lancet Oncol. 2012 Jan;13(1):25-32
references: 22153890
references: J Clin Oncol. 2008 Jan 1;26(1):44-53
references: 18165639
references: N Engl J Med. 2005 Dec 29;353(26):2747-57
references: 16382061
references: Ann Oncol. 2011 Feb;22(2):301-6
references: 20624784
references: J Clin Oncol. 2011 Sep 1;29(25):3366-73
references: 21768458
references: N Engl J Med. 2011 Oct 6;365(14):1273-83
references: 21991949
references: J Clin Oncol. 2010 Jan 20;28(3):509-18
references: 19949017
references: Lancet Oncol. 2011 Mar;12(3):236-44
references: 21354370
references: J Clin Oncol. 2006 Dec 1;24(34):5381-7
references: 17135639
references: Lancet. 2002 Jun 22;359(9324):2131-9
references: 12090977
references: Lancet. 2005 May 14-20;365(9472):1687-717
references: 15894097
references: N Engl J Med. 2004 Mar 11;350(11):1081-92
references: 15014181
references: N Engl J Med. 2009 Aug 20;361(8):766-76
references: 19692688
references: Lancet. 2010 Jan 30;375(9712):377-84
references: 20113825
references: Lancet. 2012 Feb 18;379(9816):633-40
references: 22257673